» Articles » PMID: 26918859

External Validation of Prediction Models for Pneumonia in Primary Care Patients with Lower Respiratory Tract Infection: An Individual Patient Data Meta-Analysis

Abstract

Background: Pneumonia remains difficult to diagnose in primary care. Prediction models based on signs and symptoms (S&S) serve to minimize the diagnostic uncertainty. External validation of these models is essential before implementation into routine practice. In this study all published S&S models for prediction of pneumonia in primary care were externally validated in the individual patient data (IPD) of previously performed diagnostic studies.

Methods And Findings: S&S models for diagnosing pneumonia in adults presenting to primary care with lower respiratory tract infection and IPD for validation were identified through a systematical search. Six prediction models and IPD of eight diagnostic studies (N total = 5308, prevalence pneumonia 12%) were included. Models were assessed on discrimination and calibration. Discrimination was measured using the pooled Area Under the Curve (AUC) and delta AUC, representing the performance of an individual model relative to the average dataset performance. Prediction models by van Vugt et al. and Heckerling et al. demonstrated the highest pooled AUC of 0.79 (95% CI 0.74-0.85) and 0.72 (0.68-0.76), respectively. Other models by Diehr et al., Singal et al., Melbye et al., and Hopstaken et al. demonstrated pooled AUCs of 0.65 (0.61-0.68), 0.64 (0.61-0.67), 0.56 (0.49-0.63) and 0.53 (0.5-0.56), respectively. A similar ranking was present based on the delta AUCs of the models. Calibration demonstrated close agreement of observed and predicted probabilities in the models by van Vugt et al. and Singal et al., other models lacked such correspondence. The absence of predictors in the IPD on dataset level hampered a systematical comparison of model performance and could be a limitation to the study.

Conclusions: The model by van Vugt et al. demonstrated the highest discriminative accuracy coupled with reasonable to good calibration across the IPD of different study populations. This model is therefore the main candidate for primary care use.

Citing Articles

PLUS-IS-LESS project: Procalcitonin and Lung UltraSonography-based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: study protocol for a pragmatic stepped-wedge cluster-randomized trial.

Bessat C, Bingisser R, Schwendinger M, Bulaty T, Fournier Y, Della Santa V Trials. 2024; 25(1):86.

PMID: 38273319 PMC: 10809691. DOI: 10.1186/s13063-023-07795-y.


Pulse Oximetry as an Aid to Rule Out Pneumonia among Patients with a Lower Respiratory Tract Infection in Primary Care.

Fischer C, Knusli J, Lhopitallier L, Tenisch E, Meuwly M, Douek P Antibiotics (Basel). 2023; 12(3).

PMID: 36978363 PMC: 10044291. DOI: 10.3390/antibiotics12030496.


Transparent reporting of multivariable prediction models developed or validated using clustered data (TRIPOD-Cluster): explanation and elaboration.

Debray T, Collins G, Riley R, Snell K, Van Calster B, Reitsma J BMJ. 2023; 380:e071058.

PMID: 36750236 PMC: 9903176. DOI: 10.1136/bmj-2022-071058.


Machine learning-assisted prediction of pneumonia based on non-invasive measures.

Effah C, Miao R, Drokow E, Agboyibor C, Qiao R, Wu Y Front Public Health. 2022; 10:938801.

PMID: 35968461 PMC: 9371749. DOI: 10.3389/fpubh.2022.938801.


Clinical sign and biomarker-based algorithm to identify bacterial pneumonia among outpatients with lower respiratory tract infection in Tanzania.

Hogendoorn S, Lhopitallier L, Richard-Greenblatt M, Tenisch E, Mbarack Z, Samaka J BMC Infect Dis. 2022; 22(1):39.

PMID: 34991507 PMC: 8735728. DOI: 10.1186/s12879-021-06994-9.


References
1.
Altman D, Royston P . What do we mean by validating a prognostic model?. Stat Med. 2000; 19(4):453-73. DOI: 10.1002/(sici)1097-0258(20000229)19:4<453::aid-sim350>3.0.co;2-5. View

2.
Collins G, Reitsma J, Altman D, Moons K . Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015; 162(1):55-63. DOI: 10.7326/M14-0697. View

3.
Niederman M, Mandell L, Anzueto A, Bass J, Broughton W, Campbell G . Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001; 163(7):1730-54. DOI: 10.1164/ajrccm.163.7.at1010. View

4.
Mortensen E, Coley C, Singer D, Marrie T, Obrosky D, Kapoor W . Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med. 2002; 162(9):1059-64. DOI: 10.1001/archinte.162.9.1059. View

5.
Hopstaken R, Muris J, Knottnerus J, Kester A, Rinkens P, Dinant G . Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract. 2003; 53(490):358-64. PMC: 1314594. View